Biden Pushes for Medicare, Medicaid to Cover Weight-Loss Drugs
TL;DR Summary
The Biden administration has proposed that Medicare and Medicaid cover expensive weight-loss drugs like Ozempic and Wegovy for low-income individuals and retirees, aiming to address the obesity crisis affecting 40% of Americans. This move, which could significantly increase federal spending, challenges the incoming Trump administration, particularly his health sector nominees, Robert F Kennedy Jr. and Mehmet Oz, who have differing views on the use of such drugs. The proposal could make 7.4 million people eligible for these medications, though estimates suggest many more could qualify.
- Biden proposes Medicare and Medicaid cover weight-loss drugs for 7.4m people The Guardian US
- Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal The New York Times
- Eli Lilly shares jump on two big updates and Jim Cramer is so here for it CNBC
- Biden proposes weight loss drug coverage requirements for Medicare and Medicaid NBC News
- Drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal CBS News
Reading Insights
Total Reads
1
Unique Readers
16
Time Saved
2 min
vs 3 min read
Condensed
83%
514 → 85 words
Want the full story? Read the original article
Read on The Guardian US